Serum Institute of India, Asia’s largest vaccine maker, will look at a possible merger with generic drugmaker Cipla if the European venture between the two companies succeeds. Cipla shares rose to a one-month high. “If it’s successful, then the merger ... The Financial Chronicle, 1 day ago
Serum Institute may weigh Cipla merger if European venture is successful - Livemint.com, 2 days ago
The measles virus--Courtesy of CDC In December, Serum Institute of India reported victory in a Phase I trial of its powdered measles vaccine. But now, it may have to go back to the drawing board, as results from a noninferiority trial reported ...FierceVaccines, 1 month ago Ready-to-use flu vaccine in sight Times of India, 2 months ago Intra-nasal vaccines now available in Pune Times of India, 2 months ago Take swine flu vaccination Times of India, 1 month ago
Ch Vidyasagar Rao conferred the Honorary D Litt (Honoris Causa) on Dr Cyrus Poonawalla, CMD of Serum Institute of India, for his contributions to public health through the manufacturing of low-cost vaccines.DNA, 2 months ago Guv confers D Litt on Poonawalla for contribution to health Business Standard, 2 months ago
Adar Poonawalla, executive director and chief executive officer of the world's largest vaccine producer, Serum Institute of India Ltd, said he fails to understand why people are more inclined to go for expensive swine flu diagnosis rather than opting for an ...Times of India, 2 months ago Influenza Vaccine Market in the World Is Booming! Digital Journal, 1 week ago RNCOS - Business Consultancy Services: Influenza Vaccine Market in the World is Booming! Bloomberg, 1 week ago
Researchers from Indian Veterinary Research Institute Describe Findings in Prebiotics [Effect of Feeding Jerusalem Artichoke (Helianthus tuberosus)...
Researchers from Indian Veterinary Research Institute Describe Findings in Prebiotics [Effect of Feeding Jerusalem Artichoke (Helianthus tuberosus) Root as Prebiotic on Nutrient Utilization, Fecal Characteristics and Serum Metabolite profile of ...] ...4 Traders, 2 weeks ago
Serum institute offers concession, saying it wants more people to be immune to H1N1. But some say it's a marketing stunt as demand dips It's time for the spring sale, so why should medicines be left out? Especially the swine flu ones, now that the ...Pune Mirror, 1 month ago
Deal Type: Venture Financing Deal Sub Type: Start Up Deal Country: India Deal Status: Completed Deal Value: 0.0000 USD Deal in Brief Bharat Serums and Vaccines Limited, a biopharmaceutical company, has raised funds in venture financing round.Pharmacy Choice, 1 month ago
Affiliation: Cell Biology Laboratory, National Institute of Pathology (ICMR), New Delhi, India ⨯ Madhusudan Chaturvedi, Affiliation: Cell Biology Laboratory, National Institute of Pathology (ICMR), New Delhi, India ⨯ Lakshmana Kumar ...Plosone.org, 1 month ago
With ambitious plans for the next year, Ahmedabad-based Zydus Cadila's coming launches could alter the vaccines landscape in India and challenge established players there. This week, the company announced in an earnings call that it intends to ...FierceVaccines, 20 hours ago India's Zydus Cadila has 10 vaccines in development, set to launch next year Fierce CRO, 2 days ago Cadila plans to launch 10 vaccines in India next year DNA India, 4 days ago
News 14 December 2009 INDIA - The State government has proposed to bring in a bill to prohibit slaughter of cattle, sale and possession of beef in the Bangalore State. If and when the Bill becomes Act, sale, possession and consumption of beef ...The Beef Site, 1 week ago
on your WebpageAdd Widget >Get your members hooked!